Clinical assessment of chromatic aberration in phakic and pseudophakic eyes using a simple autorefractor by Millán Garcia-Varela, M. Sagrario et al.
Clinical assessment of chromatic aberration 
in phakic and pseudophakic eyes using a 
simple autorefractor 
MARÍA S. MILLÁN,1,* FIDEL VEGA,1 FRANCISCO POYALES,2 NURIA 
GARZÓN2 
1Departament d’Òptica i Optometria, Universitat Politècnica de Catalunya, BARCELONATECH. 
ViolinistaVellsolà 37, 08222 Terrassa, Spain 
2IOA Madrid, Innova Ocular. Galileo 104, 28003 Madrid, Spain 
*m.millan@upc.edu 
Abstract: We describe a psychophysical method and a simple setup – an autorefractor with a 
Scheiner disc, sequentially illuminated with red and blue lights – for the clinical assessment 
of the longitudinal chromatic aberration (LCA) in phakic and pseudophakic patients. This 
method applies to the unaccommodated eye, even in the presence of positive or negative 
refractive errors and astigmatism. It measures the chromatic difference of refraction as an 
estimate of LCA. We built a proof of concept from inexpensive and off-the-shelf 
optomechanical components with which we obtained the preliminary clinical results 
presented in the paper. We considered one control group of phakic patients and three groups 
of pseudophakic patients with monofocal implants of different designs and materials. The 
results, satisfactory and consistent with those reported by other researchers in related works, 
demonstrate the method and system feasibility. 
© 2019 Optical Society of America under the terms of the OSA Open Access Publishing Agreement 
1. Introduction 
The optical system of the human eye is affected by a relatively high amount of longitudinal 
chromatic aberration (LCA) –about 2D in the visible spectral range (400-700nm) [1]. Such 
amount of LCA, however, has a reduced impact in vision due to several compensatory 
mechanisms: relatively large filtering of blue light in the lens and macular pigment and low 
density of the blue-sensitive cones in the cone mosaic [2–4]. The natural adaptation of human 
vision to LCA may explain the little interest for the clinical assessment and compensation of 
such aberration in phakic eyes even though binocular spatial visual acuity would benefit from 
bilateral correction of both spherical aberration and LCA [5,6]. 
LCA has recently drawn more attention with the development of advanced hybrid 
refractive-diffractive multifocal designs of intraocular lenses (IOLs) for refractive and 
cataract surgery. These designs, which combine chromatic dispersions of opposite sign 
between the refractive and diffractive parts of the IOL [7], may give pseudophakic patients a 
chance to recover their visual function with reduced chromatic aberration [8,9]. 
The chromatic characterization of IOLs on optical bench, using in-vitro techniques and 
model eyes [7,10,11] to evaluate a variety of physical metrics based on the energy efficiency 
and modulation transfer function (MTF), does not provide an immediate and comprehensive 
understanding of its impact on vision. Some researchers have developed optical setups based 
on either wavefront sensing, laser ray tracing, double-pass retinal images, and psychophysical 
techniques to precisely and effectively measure LCA in vivo of pseudophakic patients [12] 
even at various focus distances [13]. Such optical setups frequently involve the use of 
sophisticated equipment with strict alignment requirements, the assistance of highly 
specialized personnel, and the recruitment of collaborative patients for time-consuming trials. 
These drawbacks make it difficult to bring those techniques to the clinical practice and then, a 
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need arises for clinical in vivo assessment of LCA in pseudophakic patients. In an early 
contribution, Siedlecki and collaborators adapted a commercial visual refractometer to 
monochromatic measurements of refraction [14]. They replaced the standard white light 
source by a custom-designed narrow-band RGB diode, thus enabling LCA estimates through 
the measurement of the refractive error difference between the RGB wavelengths. 
In our study, we consider a psychophysical method and a simple setup that acts as 
autorefractor for the clinical assessment of LCA in phakic and pseudophakic patients. We 
apply the Scheiner principle [15] to the observation, by an unaccommodated eye, of a 
distance slit illuminated sequentially with red and blue lights. A prior application of this 
principle to the measurement of LCA was reported by Th. Young, who modified the 
Porterfield’s optometer also based on the Scheiner principle, and estimated LCA as early as 
1801 [16,17]. In a different but related system, a Badal optometer with a Vernier target was 
used to precisely determine LCA and the wavelength in focus at near and far distances [18]. 
Other reliable methods have been reported (see, for instance, Refs. 1, 19) that do not always 
require from complex optical systems or strict conditions to be implemented. However, to the 
best of our knowledge, they have not been brought to clinics yet. To be suitable for the 
clinical practice, the apparatus and the examination procedure should be based on an effective 
in vivo measurement technique. Currently, these techniques apply either subjective 
psychophysical or objective reflectometric methods [13]. In case of considering a subjective 
psychophysical method, some properties are particularly valuable: 
- Simple and straightforward application: based on a test easily understandable by ordinary 
people (the vast majority of patients are not visually trained observers); 
- Inexpensive implementation, and patient-friendly driving: a few and common-use 
optomechanical components, easy to initialize and align, robust to the presence of 
common ametropia (spherical error, astigmatism), assisted by ordinary clinical personnel, 
and very important, quick; 
- Able to provide LCA estimates in the absence of accommodation in phakic and 
pseudophakic patients comparable to other reported methods, rapid computation. 
In our proposal –an autorefractor combined with a Scheiner disc-, the chromatic refractive 
shift provides an estimate of LCA. This simple psychophysical method applies to an 
unaccommodated eye, such as in pseudophakic patients or phakic ones under mydriasis, even 
in the presence of positive or negative refractive errors and astigmatism. Although LCA is 
linearly related to the optical power of the eye, a little increase of 2.5% is predicted for each 
1D of ocular power increase [19], which is commonly higher than or in the same order as the 
target refraction in modern cataract surgery. In general, we do not expect LCA measurements 
to be importantly affected by the refractive outcome of the patient. We have developed a 
proof of concept to obtain preliminary clinical results that may demonstrate the method and 
system abilities to measure LCA in the absence of accommodation. We have considered four 
groups of patients: one control group of phakic patients under mydriasis and three groups of 
pseudophakic patients with monofocal implants of different designs and materials. We report 
the results and discuss them in the next sections. 
2. Materials, methods and patients 
2.1 Optical principles for in-vivo assessment of LCA 
The variation of the optical power of the eye with wavelength quantifies its LCA. An 
estimation of LCA can be obtained from the experimental measurement of the chromatic 
difference of refraction (CDRx) [20] from two object vergences (LB, LR) of the retinal 
conjugates of the source commonly for a short (blue, B) and a long (red, R) wavelength 
within the visible range 
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 .B RLCA CDRx L L≈ = −  (1) 
Although CDRx is a slight underestimation of the chromatic difference of focus in most eyes 
[19], many reported studies consider it as a useful estimation of LCA for practical reasons, 
and so we will do in this work. It is crucial to refer CDRx to the wavelength range used in the 
experiments before comparing results from different studies. In this study, we consider the 
range given by B = 455nm and R = 625nm, which corresponds to CDRx ≈1.2 D in normal, 
healthy eyes, according to the results adjusted from several experimental subjective studies 
reported by [1]. 
For the measurement of CDRx in eyes with no accommodation, we combine an 
autorefractor with a Scheiner disc because it allows better assessment of focus than assessing 
blur [15]. The Scheiner disc, named after Christoph Scheiner (1619), is a double pinhole 
aperture with the two pinholes separated away less than the pupil diameter. The disc is placed 
close to the eye and centered to the pupil. The subject looks through the disc at a distance 
spotlight, which in our setup is an illuminated narrow slit. Figure 1 shows the basics of the 
Scheiner principle applied to an eye that, being emmetropic for the green light (a), becomes 
myopic for the blue (b) and hyperopic for the red (c) as a consequence of LCA. Thus, while 
the subject perceives one single green image of the slit illuminated with green light –because 
the two pencils converge on a common focus on the retina (a)-, they perceive two separate 
images of the same slit for either blue or red illumination –because the retina intercepts the 
two pencils after or before they converge (b, c). 
Figure 2(a) depicts a scheme of the optical setup and how it would work for an ideal 
emmetropic eye without LCA. A white light source illuminates the slit placed at the front 
focal plane (F) of a lens. An achromat lens is used to not contribute to LCA. The emmetropic 
subject is looking through the Scheiner disc at the image of the slit formed at infinity by the 
lens. Such image at infinity conjugates the unaccommodated emmetropic eye’s retina. Should 
the eye be virtually free of LCA, the two pencils would converge on a common focus on the 
retina and the slit would be seen singly for all wavelengths. For a normal eye affected by 
LCA, a refractive error raises when looking at the slit test, which appears doubled, either 
under blue (Fig. 1(b)) or red (Fig. 1(c)) lights. 
To compensate the amount of ametropia induced by a given wavelength illumination, the 
subject needs to shift the slit away from F until an axial point O that conjugates – through the 
achromat lens and for such a wavelength- with their far point. Figures 2(b) and 2(c) show 
these adjustments, done for the red and the blue light, successively. In paraxial 
approximation, from Newton’s lens formula 2zz f= −' , with z and z’ accounting for the 
positions of object O and image O’ from the front and back focal planes (z = FO, z’ = F’O’) 
respectively, and f the achromat focal length, we obtain the vergence of the far point, which is 
given by 
 { }
12
1 , , .i i
i
fL l f k i R B
z
−
−
  
= = − + =     
 (2) 
where k corresponds to the distance between the achromat and the cornea (Fig. 2(b)), which is 
assumed to be constant. We recall that distances in the direction of light propagation are 
considered positive, otherwise negative, in Eq. (2). If zi = 0, then Li = 0. From the chromatic 
shift (X) (Fig. 2(c)), we use Eq. (2) to calculate object vergences Li for i = {R, B} and 
substitute in Eq. (1) to obtain CDRx. 
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lens is spherical, whereas the Tecnis-1 model has an anterior aspheric surface that produces a 
spherical aberration (SA) of −0.27µm for a 6mm pupil to compensate for the positive SA of 
the human cornea. The Acrysof SN60WF IOL is single-piece and composed of a copolymer 
of hydrophobic acrylate and methacrylate copolymer. It is a blue light–filtering biconvex 
sharp-edged IOL with an anterior asymmetric optic. Its aperture is 6.0mm and overall length 
13.0mm. It produces a SA of −0.20μm for 6.0mm pupil. These and further IOL parameters, 
such as the refractive index and Abbe number, which are relevant for the chromatic 
assessment of the lenses, are listed in Table 2. 
Table 2. Optical data of monofocal intraocular lensesa 
 SN60WF Tecnis-1 ZCB00 Sensar-1 AAB00 
Material Hydrophobic acrylate and methacrylate 
Hydrophobic acrylic Hydrophobic acrylic 
Refractive index n  1.55 1.47 1.47 
Abbe value V  37 55 55 
Color filter UV-blocking and blue light UV-blocking UV-blocking 
Aperture (mm) 6 6 6 
Design  
SA=c[4,0] (microns)b 
Anterior aspheric 
-0.20 
Anterior aspheric 
-0.27 
Spherical 
NAc 
a Data for 555nm wavelength and 37 °C; b SA, spherical aberration for a 6mm pupil; c NA, not applicable.  
2.4 Patients 
CDRx was measured in 74 eyes of 74 subjects. Patients were recruited and classified into two 
categories: 27 were phakic and 47 were pseudophakic implanted with one of the three types 
of monofocal IOLs (Table 2). All patients were informed about the study and provided 
informed consent to undergo the clinical examinations in accordance with the tenets of the 
Declaration of Helsinki. The study received the approval of the local ethics committee. 
We have considered two groups of phakic patients: aged >50 and aged <50 with 15 and 12 
individuals respectively. Eligible patients for the study were at least 21 years of age, no 
cataractous eyes and no co-morbidities and regular corneal astigmatism of <0.75D. Key 
exclusion criteria were irregular astigmatism, ocular comorbidities, and history of ocular 
trauma or prior ocular surgery including refractive procedures. All experiments with phakic 
subjects were conducted under mydriasis to paralyze potential accommodation (tropicamide 
1%, 2 drops 30 minutes before beginning the test). Table 3 shows the demographic and 
clinical characteristics of the phakic patients. 
 
Table 3. Descriptive data of the phakic patients  
 PHAKIC AGE>50 
 PHAKIC 
AGE<50 
Number of eyes 15  12 
Age (years) 61.73 ± 5.25 
(54 to 72) 
 33.83 ± 5.27 
(27 to 44) 
Spherical equivalent (D) -0.12 ± 2.03 
(-3.75 to 4.50) 
 -0.58 ± 1.36 
(-3.63 to 0.75) 
Visual Acuity (Decimal)a 0.99 ± 0.01 
(0.96 to 1.00) 
 0.98 ± 0.05 
(0.80 to 1.00) 
a Uncorrected Distance Visual Acuity 
 
In the case of pseudophakic patients, the inclusion criteria were: a need for cataract 
surgery, no ocular comorbidities and potential visual acuity after surgery higher than 0.8 
Decimal. Exclusion criteria were a history of ocular disease other than cataract (e.g., uveitis, 
amblyopia, glaucoma), any acute or chronic condition that would increase the risk or 
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confound study results, any capsule or zonular abnormalities that may affect post-operative 
centration or tilt of the IOL and presence of pupil abnormalities. 
The LCA was measured one month after surgery in 47 eyes of 47 subjects implanted with 
monofocal IOLs. Types of IOL implanted in the eyes of the subjects were in the following 
proportion: 13 eyes had the SN60WF (Alcon Inc.); 17 had the Tecnis-1 (Johnson & Johnson 
Vision, Inc.); 17 eyes had the Sensar-1 (Johnson & Johnson Vision, Inc.). The demographic 
and clinical characteristics of the pseudophakic patients enrolled in this study are listed in 
Table 4. There were no statistically significant differences between pseudophakic groups in 
terms of age, spherical equivalent, and visual acuity after surgery and IOL power. 
 
Table 4. Descriptive data of the pseudophakic patients  
 SN60WF Tecnis-1 ZCB00 Sensar-1 AAB00 
Number of eyes 13 17 17 
Age (years) 71.15 ± 6.28 
(64 to 87) 
67.29 ± 6.37 
(50 to 78) 
70.82 ± 4.36 
(65 to 79) 
Spherical equivalent (D) -0.29 ± 0.47 
(-1.50 to 0.25) 
-0.41 ± 0.85 
(-2.38 to 0.75) 
-0.40 ± 0.58 
(-2.50 to 0.00) 
Visual Acuity (Decimal)a 0.96 ± 0.06 
(0.80 to 1.00) 
1.01 ± 0.75 
(0.90 to 1.20) 
0.96 ± 0.07 
(0.80 to 1.00) 
IOL power (D) 19.46 ± 5.12 
(9.00 to 27.00) 
21.44 ± 2.41 
(16.50 to 27.50) 
20.91 ± 2.82 
(17.00 to 30.00) 
a Uncorrected Distance Visual Acuity 
2.5 Data analysis 
Data analysis was performed using the software SPSS for Windows version 22.0 (IBM, 
Armonk, NY, USA). Normality of data samples was evaluated by means of the Shapiro Wilk 
test. Average LCA and standard deviation were reported in descriptive analysis for IOLs. 
Independent sample t-tests were used to compare the differences in the LCA measurements 
between phakic eyes. The analysis of variables was performed using analysis of variance 
(ANOVA) and the differences were calculated using the multiple comparison Games-Howell 
test. For all statistical tests, a p-value of less than 0.05 was considered as statistically 
significance. 
3. Results 
The CDRx was measured for both categories of phakic eyes (two groups of patients aged >50 
and <50) and pseudophakic eyes (three groups of patients implanted with either monofocal 
SN60WF, Tecnis-1 ZCB00, or Sensar-1 AAB00 IOL) using the optical setup and the 
procedure described in Section 2. The results are shown in Table 5 (phakic eyes), Table 6 
(pseudopakic eyes), and Fig. 4. 
Table 5. Experimental values of LCA for phakic eyes 
 PHAKIC AGE>50 
PHAKIC 
AGE<50  
CDRx (D) 1.23 ± 0.42 (0.71 to 1.92) 
1.35 ± 0.42 
(0.69 to 2.19) 
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 Fig. 4. Experimental CDRx obtained for the two groups of phakic eyes and three groups of 
pseudophakic eyes. 
Table 6. Experimental values of LCA for pseudophakic eyes 
 SN60WF Tecnis-1 ZCB00 Sensar-1 AAB00 
CDRx (D) 0.96 ± 0.34 (0.26 to 1.44) 
0.69 ± 0.21 
(0.28 to 1.04) 
0.64 ± 0.17 
(0.33 to 0.90) 
 
The CDRx values obtained for the groups of phakic eyes (Table 5) were very similar (1.23 
± 0.42D, for the group aged>50 and 1.35 ± 0.42D for the group aged<50) and the differences 
between them were not found statistically significant (p = 0.973). The CDRx values obtained 
for the groups of pseudophakic eyes (Table 6) were generally lower than the values obtained 
for the phakics (Table 5). Such differences were found statistically significant only in the case 
of patients implanted with Tecnis-1 ZCB00 and Sensar-1. Comparing the CDRx values 
reached by pseudophakic eyes (Table 6), differences were statistically significant only 
between the SN60WF and Sensar-1 groups (p = 0.032), although the difference between 
SN60WF and Tecnis-1 groups (p = 0.095) was not far from statistical significance. Table 7 
summarizes the differences in the LCA measurements between pair of groups (p-value). 
Table 7. Differences in the LCA between pair of groups (p-value) 
 SN60WF TECNIS-1 SENSAR-1 Phakic < 50 Phakic > 50 
SN60WF - 0.095 0.032* 0.148 0.425 
TECNIS-1 0.095 - 0.859 0.002* 0.003* 
SENSAR-1 0.032* 0.859 - 0.001* 0.001* 
Phakic < 50 0.148 0.002* 0.001* - 0.973 
Phakic > 50 0.425 0.003* 0.001* 0.973 - 
4. Discussion 
The CDRx values obtained for the groups of phakic eyes are in fairly good agreement with 
those of experimental studies of CDRx as a function of wavelength reported by Thibos et al. 
[1] and Atchison and Smith [22]. Taking into account the data for Fig. 6 in Ref. 1 and for Fig. 
4 (Eq. (5a)) in Ref. 22, the CDRx corresponding to the spectral bandwidth [455nm, 625nm] is 
about 1.2D. In our study, we have measured 1.23 ± 0.42D, for the group aged>50 and 1.35 ± 
0.42D for the group aged<50, with no statistically significant difference between them (Table 
7). Our result is consistent with that reported by Siedlecki et al. for the control group of 10 
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phakic eyes (1.12 ± 0.14D) in the spectral range of 470-660nm after using an adapted visual 
refractometer [14]. And it is also consistent with the LCA obtained by Nakajima et al. for 45 
phakic eyes (1.19 ± 0.46D) in a comparable spectral region of 470-660nm using a Hartmann-
Shack wavefront aberrometer [23], as reported in Table 6 of Ref. 24. 
Although the CDRx values we measured for the groups of phakic eyes (Table 4) were 
higher than those measured for the pseudophakic group implanted with SN60WF (Alcon Inc.) 
(0.96 ± 0.34D in Table 5), the differences were not found statistically significant. This result 
agrees with those reported by other researchers, such as Nakajima et al. [24], Siedlecki et al. 
[14], and Perez-Merino et al. [12], who conducted independent experiments to ours and used 
different instruments and techniques. Nakajima et al. reported the same LCA for phakic eyes 
and 11 eyes implanted with Alcon AcrySof series (SN60WF and SN60AT) (1.30 ± 0.40D) 
[24]. Siedlecki et al. reported, in the same spectral range (470-660nm), CDRx of 1.17 ± 
0.52D and 1.12 ± 0.14D (p = 0.64) for a group of 9 eyes implanted with SN60WF and 10 
phakic eyes, respectively [14]. Perez-Merino et al. used laser ray tracing and reported LCA 
(Chromatic difference of focus) of 0.76 ± 0.12D in the spectral region 532-785nm for a group 
of 9 eyes implanted with Alcon Acrysof (SN60WF) [12], which was not significantly 
different from the value obtained in an earlier study for a phakic population 0.78 ± 0.16D 
using the same instrument [23]. 
In our study (Table 6), we obtain CDRx values for pseudophakic groups implanted with 
Johnson & Johnson IOLs (0.69 ± 0.21D for Tecnis ZCB00 and 0.64 ± 0.17D for Sensar-1) 
that are lower than the CDRx values reached by the phakics (1.23 ± 0.42D for age>50-group, 
and 1.35 ± 0.42D for age<50-group) and Alcon SN60WF pseudophakic group (0.96 ± 
0.34D). The differences are statistically significant between both Johnson & Johnson IOL 
pseudophakic groups and phakics (Table 7). The differences between the Alcon Acrysof 
SN60WF and the Johnson & Johnson groups are statistically significant in the case of Sensar-
1 and are relatively close to significance for Tecnis-1. These results are consistent with the 
dispersive characteristics of the IOL materials (Abbe number of 37 for SN60WF, and 55 for 
Tecnis ZCB00 and Sensar-1). Our results for the Johnson & Johnson IOLs are in very good 
agreement with the LCA values reported in Ref. 24 for a group 16 eyes implanted with Tecnis 
ZCB00 group (0.45 ± 0.43D) in the spectral region 470-660nm and by Pérez-Merino et al. for 
a group of 9 eyes implanted with Tecnis ZCB00 (0.46 ± 0.15D) [12]. Pérez-Merino also 
reported statistically significant difference (p<0.05) of LCA between the Tecnis group in 
comparison with LCA in phakic eyes. 
We obtained very similar CDRx values (magnitude and standard deviation) for the two 
groups of Johnson & Johnson IOLs (Tecnis-1 and Sensar-1), with no significant difference 
between them. This result leads us to acknowledge a negligible influence of the aspheric 
(Tecnis-1 ZCB00) or the spherical (Sensar-1) IOL designs in the CDRx measurements with 
our optical setup. 
In our study, inter-subject variability and standard deviations (from 0.17D to 0.42D) are 
relatively large in comparison with highly precise techniques. For instance, in Ref. 26, the 
authors reported standard deviations of 0.04D for psychophysical techniques in the visible 
spectral range (488-700nm), 0.07D using retinal images, and 0.06D using wavefront sensing 
for the visible and near infrared spectral range (450-950nm) in the presence of natural 
aberrations. However, our standard deviations are comparable to those reported in [12], [14], 
and Table 6 of [24]. We recall that, in our case, we took six measurements per patient (three 
readings times two R and B wavelengths) whereas, for instance, Siedlecki and collaborators 
took thirty (ten readings times three R, G, and B wavelengths). Since our setup is merely a 
proof of concept, there is room for improvement by refining the optomechanics of the setup 
and the procedure, particularly, for a correct alignment of the instrument with the patient’s 
pupil. 
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Our level of variability may hinder the small dependence of the chromatic difference of 
focus on ametropia (0.6% per diopter of axial ametropia and 2.4% per diopter of refractive 
ametropia, calculated for the reduced eye by Atchison et al. [27]). 
Let us remark that the procedure used in this study is robust to the presence of 
astigmatism. The orientation of the double pinhole of the Scheiner disc selects the meridian in 
which the CDRx is measured. In case of astigmatism, the positions of OR and OB would vary 
with in-plane rotations of the double pinhole, but the CDRx results (Eq. (1)) would be nearly 
constant. The stated evidence of the negligible influence of ametropia additionally supports 
this fact. 
Finally, in case of patients implanted with multifocal IOLs, the simultaneous perception of 
several double images of the slit would complicate the task and the patient would possibly 
require further training to accomplish the measurement of the CDRx for the different foci. 
5. Conclusions 
We have proved the feasibility of our method based on an autorefractor and the Scheiner disc 
to measure the CDRx of patients with null or relaxed accommodation in clinical practice. The 
results obtained for phakic and pseudophakic eyes implanted with monofocal IOLs are 
satisfactory and consistent with those reported by other researchers in related papers. This fact 
stimulates to refine the optomechanics of the setup used in this study as a proof of concept to 
improve its precision and patient-friendly driving. The method is robust to the presence of 
spherical error and astigmatism. It can be easily implemented in clinics and applied to 
pseudophakic patients implanted with monofocal (aspheric, spherical) IOLs. Further research 
is required to extend its applicability to multifocal IOL designs. 
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